Toll Free: 1-888-928-9744

Pancreatic Cancer Global Clinical Trials Review, H1, 2016

Published: May 31, 2016 | Pages: 1681 | Publisher: GlobalData | Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)

Pancreatic Cancer Global Clinical Trials Review, H1, 2016

Summary

GlobalData's clinical trial report, "Pancreatic Cancer Global Clinical Trials Review, H1, 2016" provides an overview of Pancreatic Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Pancreatic Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

- The report provides a snapshot of the global clinical trials landscape
- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
- The Report provides enrollment trends for the past five years
- Report provides latest news for the past three months

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons To Buy

- Assists in formulating key business strategies with regards to investment
- Helps in identifying prominent locations for conducting clinical trials which saves time and cost
- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
- Supports understanding of trials count and enrollment trends by country in global therapeutics market
- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
- Facilitates clinical trial assessment of the indication on a global, regional and country level

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
 Table of Contents
Table of Contents 2 List of Tables 4 List of Figures 5 Report Guidance 6 Clinical Trials by Region 7 Clinical Trials and Average Enrollment by Country 8 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10 Top Five Countries Contributing to Clinical Trials in Europe 11 Top Countries Contributing to Clinical Trials in North America 12 Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13 Top Five Countries Contributing to Clinical Trials in Central and South America 14 Clinical Trials by G7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 15 Clinical Trials by Phase in G7 Countries 16 Clinical Trials in G7 Countries by Trial Status 17 Clinical Trials by E7 Countries: Proportion of Pancreatic Cancer to Oncology Clinical Trials 18 Clinical Trials by Phase in E7 Countries 19 Clinical Trials in E7 Countries by Trial Status 20 Clinical Trials by Phase 21 In Progress Trials by Phase 22 Clinical Trials by Trial Status 23 Clinical Trials by End Point Status 24 Subjects Recruited Over a Period of Time 25 Clinical Trials by Sponsor Type 26 Prominent Sponsors 27 Top Companies Participating in Pancreatic Cancer Therapeutics Clinical Trials 28 Prominent Drugs 29 Latest Clinical Trials News on Pancreatic Cancer 30 May 18, 2016: Lilly to present data on TGF small-molecule kinase inhibitor galunisertib at ASCO 30 May 10, 2016: First Dosing of Pfizer DART Candidate in Phase 1 Study Triggers Milestone Payment to MacroGenics 30 May 09, 2016: NewLink Genetics Announces Results from Phase 3 IMPRESS Trial of Algenpantucel-L for Patients with Resected Pancreatic Cancer 31 May 05, 2016: PharmaCyte Biotech Clears Major Milestone on Path to FDA Clinical Trial 31 Apr 27, 2016: BERG Initiates Phase II Combination Trial Of BPM 31510 And Gemcitabine In Patients With Pancreatic Cancer 32 Apr 20, 2016: ARMO BioSciences Announces AM0010 Clinical Data to be Presented at the American Society of Clinical Oncology Annual Meeting in June 2016 33 Apr 20, 2016: Celldex Therapeutics Presents Data Supporting the Clinical Development of Glembatumumab Vedotin at the AACR Annual Meeting 2016 33 Apr 20, 2016: OncoMed Presents Biomarker Research for Vantictumab at the AACR Annual Meeting 2016 34 Apr 19, 2016: New class of small molecule drug, SI-2, has potential for improving cancer treatment 34 Apr 18, 2016: Halozyme Expands Oncology Pipeline With PEG-ADA2 Compound Designed For Activity In The Tumor Microenvironment 35 Apr 18, 2016: BERG Announces BPM31510 Data Presentations At 2016 AACR Annual Meeting 35 Apr 14, 2016: Asana BioSciences, to Provide First Presentation of Pre-Clinical Data on its Novel ERK 1/2 Inhibitor Program at the American Association for Cancer Research Annual Meeting 36 Apr 13, 2016: Celprogen provides an update on cancer compound CEP1430 36 Apr 13, 2016: Celprogen provides an update on cancer compound CEP1507 37 Apr 06, 2016: PharmaCyte Biotech's CEO Explains How New Clinical Trial Design Changed the GMP Certification Process 37 Apr 05, 2016: Silence Therapeutics: Atu027 update 38 Apr 05, 2016: CHK1 inhibitor CCT245737 Approved for Clinical Trials in Cancer Patients 38 Mar 31, 2016: PharmaCyte Biotech Finalizes Design of Pancreatic Cancer Clinical Trial and Identifies Trial Sites under Consideration 38 Mar 30, 2016: Verastem Announces Presentation of Scientific Data Supporting FAK Inhibition in Combination with Immunotherapy at the Keystone Symposium on Cancer Pathophysiology 39 Mar 24, 2016: Mirati Therapeutics To Present Mocetinostat Preclinical Data At 2016 American Association For Cancer Research Annual Meeting 40 Mar 22, 2016: CytRx to Present New Data Using Its Proprietary LADR Technology at the 2016 American Association for Cancer Research Annual Meeting 40 Mar 21, 2016: MabVax Therapeutics Initiates Phase I Trial of HuMab-5B1 for Treatment of Pancreatic Cancer 40 Mar 17, 2016: GlycoMimetics to Present New Preclinical Data on Its E-selectin-CXCR4 Dual Antagonist at AACR Annual Meeting 2016 41 Mar 17, 2016: Celldex Therapeutics to Present New Clinical and Preclinical Data at the AACR Annual Meeting 2016 41 Mar 07, 2016: Data from MacroGenics' Preclinical Studies of MGD009 Presented at Keystone Symposia's Antibodies as Drugs (X2) Conference 42 Mar 02, 2016: Propanc Confirms PRP Response to Broad Range of Cancer Indications; Sets Date for Scientific Advice Meeting with UK Regulators 43 Feb 24, 2016: PharmaCyte Biotech on Schedule for 2016 Cancer Clinical Trial in Pancreatic Cancer 43 Feb 22, 2016: PharmaCyte Biotech Issues Update on Preparations for Its Pancreatic Cancer Clinical Trial 44 Feb 22, 2016: OncoQR ML Pancreatic Cancer Vaccine TYG100 Induces Clinically Relevant Immune Response Within Just 2 Weeks After Single Vaccination 45 Clinical Trial Profile Snapshots 46 Appendix 1678 Abbreviations 1678 Definitions 1678 Research Methodology 1679 Secondary Research 1679 About GlobalData 1680 Contact Us 1680 Disclaimer 1680 Source 1681
List of Tables
Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region, 2016* 7 Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 10 Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 11 Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries, 2016* 12 Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2016* 13 Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 14 Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 15 Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 18 Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase, 2016* 21 Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 22 Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 26 Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29


List of Figures
Pancreatic Cancer Therapeutics, Global, Clinical Trials by Region (%), 2016* 7 Pancreatic Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 8 Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 9 Pancreatic Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 10 Pancreatic Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 11 Pancreatic Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 12 Pancreatic Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2016* 13 Pancreatic Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 14 Proportion of Pancreatic Cancer to Oncology Clinical Trials, G7 Countries (%), 2016* 15 Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 16 Pancreatic Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 17 Proportion of Pancreatic Cancer to Oncology Clinical Trials, E7 Countries (%), 2016* 18 Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 19 Pancreatic Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 20 Pancreatic Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2016* 21 Pancreatic Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 22 Pancreatic Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2016* 23 Pancreatic Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2016* 24 Pancreatic Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 25 Pancreatic Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 26 Pancreatic Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 27 Pancreatic Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 28 Pancreatic Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 29 GlobalData Methodology 1679

To request a free sample copy of this report, please complete the form below.

This website is secure and your personal details are safe. Privacy policy

Global compressed air treatment equipment market is projected to reach USD 8.59 billion by 2020, as per a new research report by Radiant Insights, Inc. Growing implementation of this equipment in various industry sectors such as healthcare & pharmace

Read More...

Europe industrial air filtration market size is projected to reach USD 1,690.8 million by 2020, as per a new research report by Radiant Insights, Inc. Increasing implementation in various industries such as metal, cement and food & beverages among ot

Read More...

Global alpha olefins market size is likely to be valued at USD 10.7 billion by 2020; as per a new research report by Radiant Insights, Inc. Increasing polyethylene demand for use in plastic production is anticipated to drive market growth. Growing ap

Read More...

Global fingerprint access control systems market size is estimated to reach USD 4.4 billion by 2022, as per a new research report by Radiant Insights, Inc. Growing safety and security concerns of individual as well as organization is projected to dri

Read More...

Global CoQ10 market size was 687.2 tons in 2014 and is expected to reach 1,168 tons by 2020, growing at a CAGR of 9.2% from 2014 to 2020, according to a new study by Radiant Insights, Inc. Increasing scope in personal care applications is expected to

Read More...
Choose License Type
Single User - US $2500
Multi User - US $5000
Why Choose Us

24/5 Research support

Get your queries resolved from an industry expert. Request for a free product review before report purchase.

Phone: 1-415-349-0054

Toll Free: 1-888-928-9744

Email: [email protected]

Custom research service

Speak to the report author to design an exclusive study to serve your research needs.

Quality assurance

A testimonial for service excellence represented in the form of BBB "A" Accreditation.

Information security

Your personal and confidential information is safe and secure.

verify